cancer talk

ASCO and the Society for Integrative Oncology issue recommendations for integrative medicine approaches that have been supported with research.

by Teresa Bergen

Cologuard and FIT have been found equally effective at screening for colorectal cancer and are widely used, but FIT is a fraction of the cost of Cologuard.

by Jon Kelvey

The practical side of cancer treatment and life without a thyroid.

by Carly Flumer

Compared with men, women’s initial cancer symptoms are less likely to be taken seriously.

by Sandra Gordon

The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2022.

by Cancer Today Staff

The editors share some of the top stories reported in Cancer Today in the past year.

Author Tara Rolle shares the challenge of staying fully present as a parent during cancer treatment and in the years that followed.

by Tara Rolle

The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.

by Eric Fitzsimmons

Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.

by Thomas Celona

Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.

by Eric Fitzsimmons